Blood test could predict dangerous heart rhythm disorder
NCT ID NCT06735001
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to find unique substances in the blood (biomarkers) that are only present in people with atrial fibrillation, a common heart rhythm problem. Researchers will compare blood samples from 400 patients with AF to those without, and track changes over time. The goal is to develop a simple test that can predict who is at risk for AF or its return, allowing for earlier and more personalized prevention.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital of Bordeaux
RECRUITINGPessac, 33604, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a smartphone alert replace daily blood thinners for AF?
- Blood fat clues could flag hidden heart rhythm risk
- Can a new heart ablation technique work without x-rays?
- Which blood thinner is safer for heart patients? a Head-to-Head test
- Smartphone light sensor may spot when an irregular heartbeat fixes itself
- Can a Wrist-Worn sensor outsmart atrial fibrillation?